P2X7 receptors in neurohypophysial terminals: Evidence for their role in arginine-vasopressin secretion

Journal of Cellular Physiology

Volumn 229, Issue 3, 2014, Pages 333-342

  Cuadra, Adolfo E ^a   Custer, Edward E ^a   Bosworth, Elizabeth L ^a   Lemos, José R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; AZ 10606120; BZATP; PURINERGIC P2X RECEPTOR AGONIST; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HORMONE RELEASE; IMMUNOREACTIVITY; MALE; NEUROHYPOPHYSIS; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; TISSUE SECTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MEMBRANE POTENTIALS; PITUITARY GLAND, POSTERIOR; PRESYNAPTIC TERMINALS; PURINERGIC P2X RECEPTOR AGONISTS; PURINERGIC P2X RECEPTOR ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X7; TIME FACTORS;

EID: 84888029732     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24453     Document Type: Article

References (57)

1. Abramoff MD, Magelhaes PJ, Ram SJ. 2004. Image processing with ImageJ. Biophotonics Int 11:36-42.
2. Allgaier C, Reinhardt R, Schadlich H, Rubini P, Bauer S, Reichenbach A, Illes P. 2004. Somatic and axonal effects of ATP via P2X2 but not P2X7 receptors in rat thoracolumbar sympathetic neurones. J Neurochem 90:359-367.
3. Anderson CM, Nedergaard M. 2006. Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons. Trends Neurosci 29:257-262.
4. Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H. 1997. Role of vasopressin in essential hypertension: Racial differences. J Hypertens 15:545-550.
5. Begley DJ. 2004. Delivery of therapeutic agents to the central nervous system: The problems and the possibilities. Pharmacol Ther 104:29-45.
6. Benarroch EE. 2005. Paraventricular nucleus, stress response, and cardiovascular disease. Clin Auton Res 15:254-263.
7. Brownstein MJ. 1983. Biosynthesis of vasopressin and oxytocin. Annu Rev Physiol 45:129-135.
8. Casas-Pruneda G, Reyes JP, Perez-Flores G, Perez-Cornejo P, Arreola J. 2009. Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia. J Physiol 587:2887-2901.
9. Custer EE, Ortiz-Miranda S, Knott TK, Rawson R, Elvey C, Lee RH, Lemos JR. 2007. Identification of the neuropeptide content of individual rat neurohypophysial terminals. J Neurosci Methods 163:226-234.
10. de Wardener HE. 2001. The hypothalamus and hypertension. Physiol Rev 81:1599-1658.
11. Deuchars SA, Atkinson L, Brooke RE, Musa H, Milligan CJ, Batten TF, Buckley NJ, Parson SH, Deuchars J. 2001. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 21:7143-7152.
12. Duan S, Anderson CM, Keung EC, Chen Y, Chen Y, Swanson RA. 2003. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci 23:1320-1328.
13. Duvernoy HM, Risold PY. 2007. The circumventricular organs: An atlas of comparative anatomy and vascularization. Brain Res Rev 56:119-147.
14. Gomes DA, Song Z, Stevens W, Sladek CD. 2009. Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors. Am J Physiol Regul Integr Comp Physiol 297:R940-R949.
15. Gordon GR, Baimoukhametova DV, Hewitt SA, Rajapaksha WR, Fisher TE, Bains JS. 2005. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat Neurosci 8:1078-1086.
16. Gutierrez-Martin Y, Bustillo D, Gomez-Villafuertes R, Sanchez-Nogueiro J, Torregrosa-Hetland C, Binz T, Gutierrez LM, Miras-Portugal MT, Artalejo AR. 2011. P2X7 receptors trigger ATP exocytosis and modify secretory vesicle dynamics in neuroblastoma cells. J Biol Chem 286:11370-11381.
17. Hew-Butler T, Jordaan E, Stuempfle KJ, Speedy DB, Siegel AJ, Noakes TD, Soldin SJ, Verbalis JG. 2008. Osmotic and nonosmotic regulation of arginine vasopressin during prolonged endurance exercise. J Clin Endocrinol Metabol 93:2072-2078.
18. Hosli E, Hosli L. 1982. Evidence for the existence of alpha- and beta-adrenoceptors on neurones and glial cells of cultured rat central nervous system-An autoradiographic study. Neuroscience 7:2873-2881.
19. Hosli L, Hosli E, Zehntner C, Lehmann R, Lutz TW. 1982. Evidence for the existence of alpha- and beta-adrenoceptors on cultured glial cells-An electrophysiological study. Neuroscience 7:2867-2872.
20. Jiang L-H. 2009. Inhibition of P2X7 receptors by divalent cations: Old action and new insight. Eur Biophys J 38:339-346.
21. Jiang LH, Mackenzie AB, North RA, Surprenant A. 2000. Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol 58:82-88.
22. Kim JE, Kang TC. 2011. The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J Clin Invest 121:2037-2047.
23. Kim M, Spelta V, Sim J, North RA, Surprenant A. 2001. Differential assembly of rat purinergic P2X7 receptor in immune cells of the brain and periphery. J Biol Chem 276:23262-23267.
24. Knott TK, Velazquez-Marrero C, Lemos JR. 2005. ATP elicits inward currents in isolated vasopressinergic neurohypophysial terminals via P2X2 and P2X3 receptors. Pflugers Arch 450:381-389.
25. Knott TK, Marrero HG, Custer EE, Lemos JR. 2008. Endogenous ATP potentiates only vasopressin secretion from neurohypophysial terminals. J Cell Physiol 217:155-161.
26. Knott TK, Hussy N, Cuadra AE, Lee RH, Ortiz-Miranda S, Custer EE, Lemos JR. 2012. ATP appears to act via different receptors in terminals vs. somata of the hypothalamic neurohypophysial system. J Neuroendocrinol 24:681-689.
27. Lemos JR. 2012. Magnocellular neurons. Encyclopedia of life sciences. Chichester: John Wiley & Sons Ltd. pp 1-6. DOI: 10.1002/9780470015902.a0000176.pub2.
28. Lemos JR, Nordmann JJ. 1986. Ionic channels and hormone release from peptidergic nerve terminals. J Exp Biol 124:53-72.
29. Leng G, Shibuki K, Way SA. 1988. Effects of raised extracellular potassium on the excitability of, and hormone release from, the isolated rat neurohypophysis. J Physiol 399:591-605.
30. Li S, Bjelobaba I, Yan Z, Kucka M, Tomic M, Stojilkovic SS. 2011. Expression and roles of pannexins in ATP release in the pituitary gland. Endocrinology 152:2342-2352.
31. Luft FC. 2007. Vasopressin, urine concentration, and hypertension: A new perspective on an old story. Clin J Am Soc Nephrol 2:196-197.
32. Marcoli M, Cervetto C, Paluzzi P, Guarnieri S, Alloisio S, Thellung S, Nobile M, Maura G. 2008. P2X7 pre-synaptic receptors in adult rat cerebrocortical nerve terminals: A role in ATP-induced glutamate release. J Neurochem 105:2330-2342.
33. Michel AD, Chessell IP, Humphrey PP. 1999. Ionic effects on human recombinant P2X7 receptor function. Naunyn Schmiedebergs Arch Pharmacol 359:102-109.
34. Michel AD, Chambers LJ, Clay WC, Condreay JP, Walter DS, Chessell IP. 2007. Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding. Br J Pharmacol 151:103-114.
35. Michel AD, Chambers LJ, Walter DS. 2008. Negative and positive allosteric modulators of the P2X(7) receptor. Br J Pharmacol 153:737-750.
36. Moores TS, Hasdemir B, Vega-Riveroll L, Deuchars J, Parson SH. 2005. Properties of presynaptic P2X7-like receptors at the neuromuscular junction. Brain Res 1034:40-50.
37. Nicke A. 2008. Homotrimeric complexes are the dominant assembly state of native P2X7 subunits. Biochem Biophys Res Commun 377:803-808.
38. Norenberg W, Schunk J, Fischer W, Sobottka H, Riedel T, Oliveira JF, Franke H, Illes P. 2010. Electrophysiological classification of P2X7 receptors in rat cultured neocortical astroglia. Br J Pharmacol 160:1941-1952.
39. North RA, Surprenant A. 2000. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563-580.
40. Pelegrin P, Surprenant A. 2006. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25:5071-5082.
41. Sawyer CH, Clifton DK. 1980. Aminergic innervation of the hypothalamus. Fed Proc 39:2889-2895.
42. 2+ accumulation in the rat. J Physiol 422:321-331.
43. Shibuya I, Tanaka K, Hattori Y, Uezono Y, Harayama N, Noguchi J, Ueta Y, Izumi F, Yamashita H. 1999. Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones. J Physiol 514:351-367.
44. Sim JA, Young MT, Sung HY, North RA, Surprenant A. 2004. Reanalysis of P2X7 receptor expression in rodent brain. J Neurosci 24:6307-6314.
45. Sladek CD, Song Z. 2008. Regulation of vasopressin release by co-released neurotransmitters: Mechanisms of purinergic and adrenergic synergism. Prog Brain Res 170:93-107.
46. Song Z, Sladek CD. 2006. Site of ATP and phenylephrine synergistic stimulation of vasopressin release from the hypothalamo-neurohypophyseal system. J Neuroendocrinol 18:266-272.
47. Stefanini M, De Martino C, Zamboni L. 1967. Fixation of ejaculated spermatozoa for electron microscopy. Nature 216:173-174.
48. Stocker SD, Wilson ME, Madden CJ, Lone U, Sved AF. 2006. Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretion stimulated by hemorrhage and hypotension but not hyperosmolality in rats. Am J Physiol Regul Integr Comp Physiol 291:R59-R67.
49. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735-738.
50. Troadec JD, Thirion S. 2002. Multifaceted purinergic regulation of stimulus-secretion coupling in the neurohypophysis. Neuro Endocrinol Lett 23:273-280.
51. 2+]i and peptide release from rat isolated neurohypophysial terminals via a P2X2 purinoceptor. J Physiol 511:89-103.
52. Valdez-Morales E, Guerrero-Alba R, Linan-Rico A, Espinosa-Luna R, Zarazua-Guzman S, Miranda-Morales M, Montano LM, Barajas-Lopez C. 2011. P2X7 receptors contribute to the currents induced by ATP in guinea pig intestinal myenteric neurons. Eur J Pharmacol 668:366-372.
53. Vavra V, Bhattacharya A, Zemkova H. 2011. Facilitation of glutamate and GABA release by P2X receptor activation in supraoptic neurons from freshly isolated rat brain slices. Neuroscience 188:1-12.
54. Virginio C, Church D, North RA, Surprenant A. 1997. Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 36:1285-1294.
55. Xia J, Lim JC, Lu W, Beckel JM, Macarak EJ, Laties AM, Mitchell CH. 2012. Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2×7 receptors. J Physiol 590:2285-2304.
56. Yan Z, Khadra A, Li S, Tomic M, Sherman A, Stojilkovic SS. 2010. Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J Neurosci 30:14213-14224.
57. Yan Z, Khadra A, Sherman A, Stojilkovic SS. 2011. Calcium-dependent block of P2X7 receptor channel function is allosteric. J Gen Physiol 138:437-452.